9/22/2011 9:25:43 AM
BALTIMORE--(BUSINESS WIRE)--Intralytix, Inc., announced today that it has entered into a Multiple Project Collaboration Agreement (“MPCA”) with The Procter & Gamble Company (NYSE:PG). “The MPCA sets the stage for Intralytix and P&G to collaborate on the development of bacteriophage (or phage) based technology for a range of applications,” stated John Woloszyn, Intralytix’s CEO. “Our phage-based technology is all natural and environmentally friendly and we look forward to this collaboration bringing forth new innovations,” Mr. Woloszyn added.
comments powered by